Sirona Biochem Corp. Stock
Your prediction
Pros and Cons of Sirona Biochem Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
S********** s********
Cons
?
M***** P*******
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Sirona Biochem Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Sirona Biochem Corp. | - | - | - | - | - | - | - |
| Satellos Bioscience Inc. | 4.410% | 5.446% | 0.472% | -29.000% | -23.929% | 175.550% | - |
| Vaxart Inc. | -0.710% | -0.639% | -15.408% | -49.275% | -58.457% | -74.601% | -95.556% |
| Larimar Therapeutics Inc. | 3.660% | 8.974% | 17.241% | -40.351% | -8.602% | -10.053% | -81.048% |
Comments
News
Dentsply Sirona (XRAY) Q2 Sales Drop 5%
Dentsply Sirona (NASDAQ:XRAY), a major player in dental products and technologies, released its second quarter results on August 7, 2025. The company reported GAAP revenue of $936 million and
